Contraceptive Procurement: How UNFPA Moves Supplies

EXECUTIVE SUMMARY

UNFPA is the world's largest procurer of contraceptives for public-sector programmes in low- and middle-income countries, accounting for approximately 40–50% of all modern contraceptives supplied to these programmes globally. This position confers significant market power — enabling UNFPA to negotiate unit prices 40–60% below what individual country governments can typically achieve — and makes UNFPA's procurement function one of the most clearly cost-effective contributions it makes to global reproductive health. Unlike many UNFPA programme areas where attribution and impact measurement are contested, the value of UNFPA's procurement function is concrete, calculable, and well-regarded by independent evaluators.

The procurement process operates through WHO-prequalified quality standards, competitive tendering, and Long-Term Agreements with pre-vetted suppliers — ensuring that supplies reaching women meet international quality thresholds and arrive reliably. UNFPA's commodity portfolio includes the full method mix: oral contraceptives, condoms, injectable contraceptives, implants, IUDs, and emergency contraception — plus maternal health commodities including post-abortion care supplies and the Reproductive Health Kit for humanitarian emergencies.

The critical weakness in UNFPA's supply chain function is the last mile: getting commodities from national warehouses to peripheral health facilities and community health workers. Supply stockouts at the point of care — not at the national delivery point — are the most common failure mode, and they are poorly tracked in UNFPA's reporting systems. Political vulnerability is a second structural weakness: the US Kemp-Kasten mechanism has repeatedly disrupted UNFPA funding, with documented impacts on contraceptive supply in affected countries.

For frontline practitioners, this document provides operational guidance on supply chain management and stockout prevention. For funders, it provides the financial context for procurement investment and the evidence base for commodity security funding. For researchers, it identifies the significant evidence gaps in supply chain science as applied to reproductive health commodities.

KEY FACTS

UNFPA procures approximately 40–50% of all modern contraceptives supplied to public-sector programmes in low- and middle-income countries — the largest procurement share of any single organisation globally.
UNFPA's scale purchasing achieves price reductions of 40–60% compared to comparable national procurement — a concrete cost-effectiveness dividend for programme countries.
UNFPA Supplies, the dedicated division responsible for procurement and supply chain management, is headquartered in Copenhagen, Denmark, and manages a procurement portfolio of approximately USD 200–250 million per year in reproductive health commodities.
All UNFPA-procured products must meet WHO prequalification standards or equivalent (US FDA, European EMA stringent regulatory authority approval) — a non-negotiable quality requirement.
UNFPA's standard commodity portfolio includes: oral contraceptive pills, condoms (male and female), injectable contraceptives (DMPA and Sayana Press), sub-dermal implants (Jadelle, Nexplanon, Implanon), copper IUDs, emergency contraception (levonorgestrel 1.5mg), manual vacuum aspiration kits for post-abortion care, and the UNFPA Reproductive Health Kit.
Commodity stockouts at the facility level — not at the national delivery level — are the most common supply chain failure mode; UNFPA's routine reporting systems do not adequately track sub-national stockout rates.
The 2017 US Kemp-Kasten defunding of UNFPA resulted in documented contraceptive stockouts across multiple African and Asian countries; independent analysis estimated millions of women affected.
COVID-19 disruption to global contraceptive supply chains in 2020 caused an estimated 3–4 month delay in commodity delivery across UNFPA's supply network, with resulting stockouts in 37 countries per UNFPA's own monitoring.
Contraceptive method mix management is a specific programme area: UNFPA advocates for — and supports countries to implement — full method mix availability rather than limited method programmes, recognising that rights-based family planning requires genuine choice.
Forecasting accuracy is a critical supply chain metric: inaccurate demand forecasting produces both stockouts (too little) and wastage/expiry (too much); UNFPA provides technical assistance for quantification as a core programme service.
UNFPA's Long-Term Agreements (LTAs) with pre-vetted suppliers provide price certainty and supply reliability — currently active LTAs cover the majority of UNFPA's standard commodity range.
The reproductive health commodity security gap — the difference between needed and funded commodities globally — was estimated at USD 700 million per year pre-COVID; post-COVID supply chain disruptions have not reduced this gap.
Implant market transformation: UNFPA, through volume purchasing commitments, contributed to a dramatic reduction in sub-dermal implant prices from approximately USD 18–20 per unit in 2012 to approximately USD 8.50 per unit by 2014, making implants accessible for low-income country programmes.
UNFPA's RH Kit — pre-packaged reproductive health supplies for humanitarian settings — is one of UNFPA's most widely recognised products; approximately 750+ kit modules were deployed in 2023 across 40+ humanitarian response operations.
The FP2030 commitment framework (successor to FP2020) includes specific contraceptive security commitments from donors and governments that UNFPA's procurement function supports and tracks.
Sayana Press (subcutaneous DMPA) — a self-injectable contraceptive — has been promoted by UNFPA as a demand-side innovation enabling community health worker and self-injection administration, with procurement support integrated into UNFPA's injectable contraceptive supply.

BACKGROUND AND CONTEXT

Why UNFPA Functions as a Contraceptive Procurer

The origins of UNFPA's procurement role lie in the structural market failures of contraceptive supply in low-income countries. Individual low-income country governments face several disadvantages as direct contraceptive purchasers:

Volume disadvantage: Small national markets mean small order volumes, which translate into higher unit prices from manufacturers and limited supplier competition. UNFPA's simultaneous purchasing for dozens of countries creates the volume needed to attract competitive tendering and negotiate lowest prices.

Technical capacity constraints: International pharmaceutical procurement requires specialist expertise — WHO prequalification assessment, supplier qualification auditing, tender management, quality testing logistics, and contract negotiation. Most low-income country procurement agencies lack this capacity or cannot sustain it reliably.

Relationship and intelligence advantages: Long-term relationships with qualified contraceptive manufacturers give UNFPA market intelligence on product quality, supply reliability, production capacity, and upcoming regulatory changes that individual country procurement cannot access.

Financing and cash flow advantages: UNFPA can advance procurement financing to countries and can maintain buffer stocks ahead of confirmed orders, providing supply chain resilience that individual country programmes cannot achieve.

The combined effect is that UNFPA procurement delivers better quality products at lower prices with greater supply reliability than most national procurement alternatives. This is not a theoretical argument — it is borne out in comparative price data published in UNFPA Supplies annual reports and confirmed by multiple independent evaluations.

Historical Development

UNFPA's commodity procurement function began in the 1970s as a straightforward fund-and-procure model for early population programmes. The UNFPA Supplies programme evolved into its current form over several decades, adding quality assurance systems, supply chain technical assistance, humanitarian supplies programming, and market shaping activities (working with manufacturers to increase supply capacity and reduce prices for specific methods).

The FP2020 and FP2030 frameworks — voluntary commitments by governments and donors to expand access to family planning — provided a new architecture for contraceptive security tracking and for mobilising additional commodity funding. UNFPA's procurement function is directly linked to these frameworks as the implementation mechanism for commodity commitments.

WHAT UNFPA DOES: PROGRAMME DETAIL

The Procurement Process

Supplier qualification and Long-Term Agreements: Before any product can be procured by UNFPA, the supplier must be qualified. Qualification requires demonstrated compliance with WHO prequalification standards or equivalent stringent regulatory authority approval (US FDA, European EMA). UNFPA then enters Long-Term Agreements (LTAs) with qualified suppliers — multi-year supply agreements with pre-negotiated prices, delivery standards, and quality requirements. LTAs provide price certainty, enable multi-country order aggregation, and create an incentive for suppliers to maintain quality (continued LTA status depends on performance).

Demand aggregation and tendering: For commodities not covered by existing LTAs, or when LTA pricing is challenged, UNFPA conducts competitive tenders. Country offices submit demand forecasts; UNFPA aggregates these into a single international tender volume; qualified suppliers bid; UNFPA evaluates on price, quality, and delivery reliability. Aggregation is the mechanism through which volume discount is achieved — each country's small demand contributes to the total volume that drives competitive pricing.

Order management and logistics: Once orders are placed, UNFPA manages logistics from factory to country port of entry (typically). Country-level logistics — from port to national medical store — is typically a government responsibility, with UNFPA providing technical assistance where needed. From national medical store to peripheral facility (the last mile) is where the supply chain most frequently fails.

Quality control programme: UNFPA maintains an active post-delivery quality testing programme. Samples of delivered products are tested at WHO-accredited laboratories against product specifications. Products failing post-delivery testing trigger supplier notification, potential LTA suspension, and where necessary, product recalls. This active quality surveillance is a distinguishing feature of UNFPA procurement versus national procurement, which often lacks post-delivery testing capacity.

The Full Method Mix

Rights-based family planning requires that women and couples can choose from a full range of modern methods, not be steered toward whatever method is most available or cheapest. UNFPA's method mix policy requires that programme support includes access to all major modern methods:

Short-acting methods:

Combined oral contraceptive pills (COCs): most commonly used method globally; procured in large volumes.
Progestogen-only pills (POPs): used where COCs are contraindicated; smaller volume.
Male condoms: procured in hundreds of millions annually; dual protection against pregnancy and STI/HIV.
Female condoms: procured in smaller volumes; important for women's agency in protection.
Emergency contraception (EC, levonorgestrel 1.5mg): critical for post-coital pregnancy prevention; also used for post-rape care in GBV response.

Injectable contraceptives:

DMPA (depot medroxyprogesterone acetate, Depo-Provera): highly popular in sub-Saharan Africa; administered quarterly by health workers.
Sayana Press (DMPA-SC): subcutaneous formulation in Uniject device; can be self-administered or administered by community health workers without clinical training; major innovation for last-mile access.

Long-acting reversible contraceptives (LARCs):

Sub-dermal implants (Jadelle, Nexplanon/Implanon): 3–5 year effectiveness; requires clinical insertion and removal; highly effective; UNFPA's market shaping work contributed to price reduction.
Copper IUDs: 5–10 year effectiveness; highest up-front effectiveness; requires trained insertion; cold chain not required.

Post-abortion care supplies:

Manual vacuum aspiration (MVA) kits: for management of incomplete abortion and post-abortion care.
Misoprostol: included in procurement for medical management of miscarriage and post-abortion care.

Reproductive Health Kits: Pre-packaged kits for humanitarian emergencies, covering clean delivery, emergency obstetric care, post-abortion care, GBV clinical management, and STI treatment. Designed for deployment within 72 hours of emergency onset; available in multiple configurations for different levels of care.

Forecasting and Quantification Technical Assistance

Accurate demand forecasting — quantifying how many of each product will be needed over a one-to-two year planning horizon — is the foundation of supply chain reliability. Overstocking leads to expiry and wastage; understocking leads to stockouts. Both are costly.

UNFPA provides forecasting technical assistance to country programmes through:

Training in quantification methods (consumption-based and demographic-based approaches).
Facilitated national quantification exercises with government data, programme data, and DHS/MICS data inputs.
Access to Quantimed and PipeLine software tools for supply planning.
Data review and quality checking support.

The challenge is that forecasting is only as good as the underlying data — service statistics data quality (completeness of reporting from peripheral facilities), population data accuracy, and contraceptive prevalence data reliability all affect forecast accuracy. In countries with weak health information systems, even well-conducted forecasting exercises produce estimates with wide uncertainty ranges.

Commodity Security and the FP2030 Framework

Commodity security — assurance that reproductive health commodities are continuously available to all who need them — is a programme goal that goes beyond procurement. It requires: adequate financing (donor and government), reliable procurement, functional logistics and distribution, and facility-level stock management. UNFPA contributes to commodity security across all these dimensions:

Financing advocacy: Working with governments and donors to secure adequate commodity budgets; participating in the FP2030 process to track and hold accountable the commodity financing commitments.
Domestic resource mobilisation: Supporting governments to progressively increase domestic financing for commodity procurement, reducing dependence on donor funding.
Procurement and supply chain technical assistance: Direct support for all phases of the supply chain.
Last-mile logistics support: Supporting logistics management information systems (LMIS) that track stock levels, flag reorder points, and identify supply bottlenecks at facility level.

THE EVIDENCE BASE

Evidence on UNFPA Procurement Value

The value of UNFPA's procurement function rests on three demonstrable claims: (a) quality is higher than alternative procurement sources, (b) prices are lower, and (c) supply reliability is better. The evidence for all three is strong:

Quality: WHO prequalification and UNFPA's post-delivery testing programme provide rigorous quality assurance. Multiple independent evaluations have confirmed that UNFPA-procured products consistently meet quality specifications. By contrast, national procurement in many low-income countries has documented quality problems — failed contraceptives, contaminated products, and substandard pharmaceutical ingredients — that UNFPA's quality system prevents.

Price: UNFPA Supplies annual reports publish price comparison data for key commodities. The price advantage over comparable national procurement averages 40–60% for most methods. The implant price reduction — from approximately USD 18–20 per unit in 2012 to USD 8.50 by 2014, achieved through UNFPA's volume commitment combined with Gates Foundation co-funding — is a specific documented example of market transformation impact.

Supply reliability: UNFPA's LTA system and buffer stock maintenance provide supply continuity that national procurement cannot match. The COVID-19 disruption period demonstrated both the strength of the system (UNFPA maintained supply to more countries more consistently than most bilateral procurement systems) and its limits (a 3–4 month average delay was still experienced).

Evidence on Last-Mile Supply Chain Effectiveness

The evidence on UNFPA's last-mile supply chain effectiveness is much weaker than for procurement itself. The reason: UNFPA's routine monitoring and reporting systems track commodity delivery to country-level (port of entry or national medical store), not distribution below that level. This creates an evidence gap at precisely the point where supply chain failure most frequently occurs.

Country-level evaluations and supply chain assessments (conducted by JSI, USAID Supply Chain for Health programme, and others) consistently identify stockout rates at health facility level as the critical performance metric that is not adequately tracked. In several evaluations, facilities were found to have zero stock of one or more key contraceptive methods more than 30% of the time — a rate entirely inconsistent with reliable family planning access, but invisible in UNFPA's national-level reporting.

LMIS strengthening evidence: The evidence that well-implemented logistics management information systems improve supply chain performance is moderate. Studies from Ethiopia, Rwanda, and Uganda have documented improvements in stockout rates following LMIS implementation, but methodological limitations (pre-post designs, confounding from simultaneous system improvements) make precise attribution difficult.

Evidence on Commodity Security's Impact on Family Planning Use

The connection between commodity security and contraceptive use is logically obvious but has been empirically examined in a limited number of studies. The most direct evidence comes from natural experiments — situations where commodity availability changed for external reasons:

2017 US defunding: The Kemp-Kasten defunding of UNFPA in 2017 created a natural experiment. Donor analysis (Guttmacher Institute, 2018) estimated that the defunding would cause stockouts affecting millions of women across affected countries. Country-level programme monitoring in Kenya, Uganda, and other affected countries documented stockout increases of key methods in the months following the funding withdrawal. This is the strongest available evidence that supply disruption translates into access reduction.

COVID-19 supply disruption: UNFPA's own analysis documented that the 2020 supply chain disruption led to stockouts in 37 countries, with estimated contraceptive access reduction leading to 1.4 million additional unintended pregnancies. This estimate is based on modelling assumptions about demand suppression from stockouts — it is a projection rather than a measured outcome — but the direction and order of magnitude are credible.

Evidence Quality Assessment (GRADE-Style)

UNFPA procurement achieves lower prices than national procurement: Strong evidence (consistent across multiple commodity categories; documented in UNFPA Supplies reports and confirmed by independent evaluations).
UNFPA-procured products meet quality standards: Strong evidence (WHO prequalification standard; active quality testing programme; documented in supplier audit reports).
LMIS strengthening improves facility-level stockout rates: Moderate evidence (positive evaluations from multiple countries; methodological limitations in attribution).
Commodity stockouts reduce contraceptive use: Moderate evidence (natural experiment evidence from 2017 defunding; modelling evidence from COVID-19; logical mechanism well-established).
UNFPA's last-mile support reduces peripheral stockout rates at scale: Weak evidence (poor monitoring; limited controlled evaluations of UNFPA-specific last-mile interventions).

IMPLEMENTATION REALITIES

The Last-Mile Problem in Practice

Supply chain management below the national level is among the most persistently problematic areas in public health programme implementation globally — not only in UNFPA's work, but across health commodity supply chains in low-income countries. The specific failure modes in contraceptive supply are:

Facility-level stock management: Health workers at rural health posts are typically multi-purpose — they provide curative care, maternal health services, immunisation, and family planning, among other services. Stock management (recording stock received, tracking consumption, calculating reorder points, submitting orders on time) competes with clinical work for time and attention. It is also rarely a training priority in pre-service health worker education. The result: facilities routinely hold either excessive stock (of methods they receive without requesting, delivered through push-based supply systems) or zero stock (of methods not automatically delivered and for which no order was placed).

The push versus pull supply system: Two models of supply replenishment exist. In push systems, a central warehouse periodically sends a standardised package of supplies to peripheral facilities regardless of their consumption or current stock level. In pull systems, facilities order based on their actual consumption and current stock (using LMIS data). Push systems are simpler to administer but produce systematic over- and under-supply. Pull systems produce more accurate supply but require functional LMIS and trained stock managers. Most low-income country health systems use hybrid push-pull systems that inherit the weaknesses of both — UNFPA supports the transition toward pull-based systems, but this is a multi-year system change.

Transportation and resupply frequency: In remote areas, resupply happens infrequently — quarterly or less — because of transportation cost and road access constraints. This means facilities must hold three to four months of stock between deliveries and must accurately forecast their needs that far in advance. Stock management errors compound over longer resupply intervals.

Leakage: Contraceptive supplies are diverted from public facilities to private markets in some contexts — either through outright theft or through formal parallel distribution (health workers selling public sector supplies). Leakage rates are poorly quantified but are documented in assessments from multiple sub-Saharan African countries. The extent to which leakage represents a programme failure (supplies not reaching intended beneficiaries at no cost) versus a market adaptation (reaching users through alternative distribution channels) is debated.

Donor Funding Volatility and the Kemp-Kasten Risk

The US government has historically been a major contributor to UNFPA, including to commodity procurement. The Kemp-Kasten Amendment authorises the US President to withhold funding from any organisation that "supports or participates in the management of a program of coercive abortion or involuntary sterilisation" — a provision that has been applied to UNFPA multiple times, most significantly in 2002–2008 and again in 2017–2021, during Republican administrations that concluded (without credible evidence) that UNFPA met this criterion.

The supply chain consequence of Kemp-Kasten is concrete: when US funding is withdrawn, UNFPA's procurement capacity for affected countries is reduced, forcing either other donor burden-sharing (not always available at short notice) or programme-level commodity reductions. The 2017 defunding resulted in documented stockouts in several African countries within six to twelve months.

Programme designers and country offices must plan for this risk. Mitigation strategies include: diversifying donor funding for commodity procurement (reducing dependency on any single donor); building additional buffer stock ahead of potential US defunding; and identifying alternative procurement vehicles (IPPF, national programmes) that can partially substitute for UNFPA procurement.

COVID-19 as a Supply Chain Stress Test

The COVID-19 pandemic was the largest global contraceptive supply chain disruption in decades. The mechanisms:

Manufacturing disruption: major contraceptive manufacturers in India (including the Serum Institute and others producing generics) and Bangladesh temporarily reduced or suspended production due to factory lockdowns and worker illness.
Logistics disruption: international freight networks were severely disrupted; container shortages, port closures, and airline freight capacity reduction created delays of two to four months for sea freight deliveries.
Last-mile disruption: community health worker deployment was suspended in some countries; health facility closures reduced service points; lockdowns prevented women from reaching facilities.
Demand-side disruption: fear of COVID exposure deterred clinic attendance even when facilities remained open.

UNFPA's response included: activating strategic buffer stocks; adjusting procurement towards air freight for critical commodities; supporting country offices to adopt contactless service delivery and community health worker distribution; and rapidly developing guidance on maintaining contraceptive supply during pandemic conditions.

The COVID-19 experience revealed both the resilience of UNFPA's upstream supply chain (quality and procurement systems held up well) and the persistent vulnerability of last-mile logistics (stockouts at facility level increased significantly in many countries).

The Method Mix and Access Inequity

An analysis of UNFPA procurement data across programme countries reveals a structural inequity: in many countries, injectable contraceptives (primarily DMPA) constitute a disproportionately large share of the procured method mix, while LARCs (implants and IUDs) remain relatively under-supplied in peripheral facilities. The reasons are partly economic (LARCs require trained providers for insertion/removal, which many peripheral facilities lack) and partly systemic (push-based supply systems deliver what they have always delivered).

The consequence is that women in remote areas often face a choice between injectable contraceptives and barrier methods — not the full method mix that UNFPA's policy requires. Women who would prefer implants (highly effective, self-maintaining, three to five years) often cannot access them because trained providers are not available at their nearest facility.

Addressing the method mix access gap requires both supply chain action (stocking LARCs at peripheral facilities) and workforce action (training community health workers in LARC removal at minimum, and in insertion where feasible). This intersection of supply chain and workforce programming is an area where UNFPA's two major commodity functions — procurement and health worker training — should coordinate more effectively.

FUNDING, SCALE AND RESOURCES

UNFPA Supplies Budget

UNFPA Supplies operates with an annual commodity procurement budget of approximately USD 200–250 million — derived from donor contributions, service fees from governments receiving procurement support, and UNFPA core resources. The Copenhagen-based operation has approximately 100 staff with specialist expertise in pharmaceutical procurement, quality assurance, logistics, and supply chain management.

Donor Contributions to Commodity Procurement

The Netherlands, United Kingdom (FCDO), Sweden (Sida), Norway, Canada (Global Affairs Canada), and the European Union are the primary bilateral donors to UNFPA's commodity procurement function. The US government, when not defunded, has historically been a significant contributor through USAID reproductive health commodity funding and PEPFAR (for condoms for HIV prevention).

FP2030 commitments include specific commodity security financing pledges from donor governments — total donor commodity commitments in the 2020 FP2030 cycle were approximately USD 400 million per year, of which UNFPA administers a significant proportion.

Cost-Effectiveness of the Procurement Function

The price advantage UNFPA achieves — 40–60% below national procurement alternatives — translates directly into the cost-effectiveness calculation for procurement investment. If UNFPA procures USD 200 million in contraceptives at 50% of what national procurement would cost, the effective value delivered is equivalent to USD 400 million in procurement capacity. This cost-efficiency argument is among the strongest available for any UNFPA function.

The Reproductive Health Supplies Coalition (RHSC) has documented the global commodity security financing gap — the difference between needed funding and available funding — at approximately USD 700 million per year pre-COVID. UNFPA's procurement efficiency directly reduces this gap by stretching available funding further.

KEY DEBATES AND CONTESTED QUESTIONS

1. Should UNFPA Advocate More Strongly for Domestic Resource Mobilisation?

A persistent tension in commodity security is between external procurement support (UNFPA buying contraceptives for country programmes) and domestic resource mobilisation (country governments progressively increasing their own commodity financing). Current programme design includes domestic resource mobilisation as a programme goal — but in practice, external procurement support sometimes reduces the political pressure on governments to increase domestic commodity financing. The debate is whether UNFPA should be more explicit about exit strategies and domestic financing timelines in its commodity support.

2. How Should UNFPA Respond to the Self-Injection Revolution?

Sayana Press (DMPA-SC) enables self-injection of a highly effective injectable contraceptive, eliminating the need for a clinic visit. Evidence from Uganda, Senegal, Niger, and other countries shows high acceptability and continuation rates among self-injection users. Self-injection could dramatically expand effective contraceptive access, particularly in remote areas.

UNFPA has incorporated Sayana Press into its commodity portfolio and supported self-injection programme scale-up. The debate is about: how aggressively to prioritise Sayana Press in supply mixes (it is more expensive per unit than standard DMPA); what level of initial provider counselling is needed before self-injection is appropriate; and whether the supply chain for Sayana Press (different from standard DMPA) can be adequately managed at peripheral level.

3. Centralised Procurement Versus Country-Level Market Development

UNFPA's centralised procurement model has undeniable advantages, but critics (including some public health economists) argue that sustained reliance on UNFPA procurement prevents the development of domestic pharmaceutical markets and regulatory systems in programme countries. If UNFPA procures internationally in perpetuity, country governments never develop the procurement expertise, supplier relationships, and regulatory systems needed to sustain supply independently.

The counter-argument: in the near term, the quality and cost advantages of UNFPA procurement are too large to sacrifice for the speculative long-term benefit of domestic market development. And UNFPA does provide technical assistance for procurement capacity development alongside direct procurement — though this component of UNFPA's work is less visible and less funded.

4. How to Track and Report Last-Mile Stockouts

The methodological and political challenge of last-mile monitoring is a genuine debate. The current approach — tracking national-level delivery — is measurable but misleading (it measures supply entering the system, not supply reaching users). Facility-level stockout monitoring would be more meaningful but requires functioning health information systems, consistent reporting from thousands of facilities, and significant analytical capacity. The argument for accepting national delivery metrics as a proxy is pragmatic; the argument for investing in better sub-national monitoring is about programme integrity and donor accountability.

IMPLICATIONS BY AUDIENCE

For Frontline Staff and Practitioners

Supply stockouts are a predictable problem, not an occasional emergency. Plan for them. The two most important stock management tools at facility level are: (a) a current stock card for each method, updated every time supplies are received or dispensed; and (b) a defined reorder point — the stock level at which you submit a resupply request (typically set at two months' supply, to allow for ordering lead time without running out). Facilities that do not have current stock records cannot manage their supplies; without records, you are always reactive rather than preventive.

When a stockout occurs: document it (date, product, expected duration); inform the client clearly of alternatives available; provide bridging if alternative methods are appropriate; record the stockout in your facility monitoring; and report upward immediately — stockouts should not be quietly absorbed at facility level.

For Sayana Press/self-injection: the evidence for self-injection is positive. If you have clients who express interest in self-injection, are appropriate candidates (using injectable DMPA, no contraindications), and can demonstrate correct injection technique after training, self-injection is a legitimate service option that empowers clients and reduces clinic visit burden.

The method mix matters for rights-based family planning. If your facility consistently has gaps in specific methods — particularly LARCs — document these gaps and report them through supervision channels. A facility that routinely offers only injectables and pills is not providing genuine contraceptive choice.

For Programme Managers and Decision-Makers

Procurement data is the most reliable data in the supply chain; facility-level availability data is the least reliable. Build your supply chain monitoring system around the weakest link, not the strongest. Invest in LMIS implementation or strengthening that captures facility-level consumption and stockout data — and build accountability mechanisms that respond to facility-level stockout reports, not just national delivery statistics.

Supply chain investment should be matched by forecasting investment. A well-funded procurement function with poor forecasting produces either stockouts or wastage. Prioritise quantification technical assistance alongside commodity procurement support — treat them as a linked system.

Donor funding volatility is a programme risk that should be in every country programme risk register. Develop a contingency plan that specifies: what happens if UNFPA's commodity procurement budget is cut by 30%; what alternative procurement mechanisms exist; what buffer stock level is needed to provide six months of supply security; and what government resources could be mobilised on short notice to fill a procurement gap.

For Donors and Board Directors

The procurement function is UNFPA's most clearly cost-effective contribution and the easiest to attribute. Every USD 1 contributed to UNFPA Supplies buys approximately USD 1.70–2 worth of commodities compared to what national procurement would achieve with the same funding — the price advantage is a direct efficiency gain. For value-for-money-focused funders, commodity procurement is the UNFPA function with the most direct and measurable return.

Last-mile logistics is the underfunded and under-evidenced weak link. If donors seek to maximise impact of supply chain investment, funding should complement upstream procurement with downstream logistics support: LMIS development, supply chain manager training, transportation support for remote areas, and monitoring systems that track facility-level availability rather than national delivery volumes.

Commodity security financing should be treated as a long-term commitment, not a one-year grant. The supply chain planning horizon is twelve to eighteen months from order to facility delivery; funding received with less than twelve months' notice cannot be effectively deployed. Multi-year, predictable commodity financing commitments are significantly more valuable than equivalent annual commitments.

For Researchers

The supply chain evidence base for reproductive health commodities has significant gaps that limit effective programme design:

Last-mile stockout quantification: The actual prevalence of facility-level stockouts for specific contraceptive methods across UNFPA programme countries is poorly quantified. A systematic, standardised facility survey methodology (comparable to the Service Provision Assessment surveys used in DHS) applied across multiple countries would establish the baseline from which supply chain intervention research could proceed.
Impact of stockouts on contraceptive use and unintended pregnancy: The causal relationship between stockout events and contraceptive discontinuation, method switching, and unintended pregnancy is poorly documented. Natural experiments from the 2017 US defunding and COVID-19 disruption provide opportunities for retrospective analysis that has been only partially exploited.
Self-injection scale-up evidence: The evidence base for self-injection programmes is positive but thin — mostly small studies from specific settings. Scale-up implementation research examining what programme design features enable high-quality self-injection service delivery at national scale is needed.
Domestic resource mobilisation effectiveness: Does UNFPA's commodity security technical assistance (as distinct from direct procurement) effectively build domestic government capacity and increase domestic budget allocation? No rigorous evaluation of this component exists.
Method mix determinants: What determines the method mix available at peripheral facilities in different country contexts? Are supply-side factors (what UNFPA ships), provider factors (what providers offer), or demand factors (what clients request) the primary determinant? Understanding this would guide targeted supply chain intervention.

CURRENT STATUS AND FUTURE DIRECTIONS

UNFPA's procurement function continues as a central operational priority under the 2022–2025 Strategic Plan. Post-COVID supply chain resilience — diversified supplier relationships, improved buffer stock management, and strengthened country-level LMIS — has been the dominant operational focus since 2021.

The FP2030 framework provides the political architecture for commodity security advocacy. UNFPA's commodity procurement is explicitly linked to FP2030 country commitments, creating a channel for tracking whether committed financing is translating into commodity availability.

Sayana Press and self-injection scale-up continues across programme countries, with growing evidence supporting the approach. Digital supply chain tools — mobile LMIS platforms, drone delivery pilots in Kenya and Rwanda, and supply chain visibility platforms — are being tested and partially integrated into UNFPA's last-mile support.

The fiscal environment remains constrained: the 2024–2025 global development funding environment is marked by aid budget cuts across major bilateral donors, with direct implications for commodity security financing. UNFPA's ability to maintain procurement volumes while donor contributions decrease will be tested in the coming biennium.

SOURCES

UNFPA Supplies Annual Reports (2020–2024): Primary source for procurement volumes, prices, quality performance, and supply chain statistics. Available at unfpa.org/supplies. The most reliable data source for UNFPA's commodity function.

UNFPA (2022): Reproductive Health Commodity Security: Global Programme Review. Internal programme review of supply chain performance, lessons from COVID-19, and supply chain resilience strategy.

Reproductive Health Supplies Coalition (RHSC) (2023): Contraceptive Security Indicators and Funding Gap Analysis. Annual tracking of the global commodity security financing gap. Available at rhsupplies.org.

Guttmacher Institute (2018): The Estimated Impact of Withdrawing US Support From UNFPA. Analysis of the supply chain consequences of the 2017 Kemp-Kasten defunding. The most specific available analysis of funding withdrawal impact on commodity access.

WHO Prequalification Programme: Documentation of WHO prequalification standards and qualified product lists. Available at extranet.who.int/pqweb. The quality assurance foundation for UNFPA procurement.

Track20 / FP2030 Secretariat (2023): Family Planning Progress Reports. Tracks FP2030 commitment status, commodity security financing, and programme results by country. Available at track20.org and fp2030.org.

PATH (2018): Self-Injection of DMPA-SC: Evidence, Programme Experience, and Policy. Synthesis of evidence and programme learning on Sayana Press self-injection. Key reference for self-injection programme design.

USAID | DELIVER PROJECT (2011): Supply Chain Management System Functional Standard. Technical reference for supply chain management system design in low-income country health systems.

JSI Research & Training Institute: Country-level supply chain assessments (published for multiple UNFPA programme countries). Provides facility-level stockout data that national reporting does not capture.

UNFPA IEO: Country evaluation reports that include supply chain components. Multiple evaluations have identified the last-mile tracking gap as a programme weakness.